These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15589636

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).
    Pfisterer M, Trial of Invasive versus Medical therapy in Elderly patients Investigators.
    Circulation; 2004 Sep 07; 110(10):1213-8. PubMed ID: 15337691
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
    Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG, Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators.
    Circ Cardiovasc Qual Outcomes; 2008 Sep 07; 1(1):12-20. PubMed ID: 20031783
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT, Morrison DA, Hlatky MA, Barnett PG, Cao L, Lyttle C, Hynes DM, Henderson WG, Investigators of Veterans Affairs Cooperative Studies Program #385 (AWESOME: Angina With Extremely Serious Operative Mortality Evaluation).
    Circulation; 2006 Sep 19; 114(12):1251-7. PubMed ID: 16966588
    [Abstract] [Full Text] [Related]

  • 5. Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.
    Favarato D, Hueb W, Gersh BJ, Soares PR, Cesar LA, da Luz PL, Oliveira SA, Ramires JA, First Year Follow-Up of MASS II Study.
    Circulation; 2003 Sep 09; 108 Suppl 1():II21-3. PubMed ID: 12970202
    [Abstract] [Full Text] [Related]

  • 6. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Whitlow PL, Wiens RD.
    Circulation; 2004 Oct 05; 110(14):1960-6. PubMed ID: 15451795
    [Abstract] [Full Text] [Related]

  • 7. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z, Mahoney EM, Spertus JA, Booth J, Nugara F, Kolm P, Stables RH, Weintraub WS.
    Am Heart J; 2006 Dec 05; 152(6):1153-60. PubMed ID: 17161069
    [Abstract] [Full Text] [Related]

  • 8. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A.
    J Cardiovasc Med (Hagerstown); 2007 Aug 05; 8(8):596-601. PubMed ID: 17667030
    [Abstract] [Full Text] [Related]

  • 9. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD, Schwenkglenks M, Rutishauser W.
    Med Klin (Munich); 2000 Jan 15; 95(1):1-13. PubMed ID: 10668338
    [Abstract] [Full Text] [Related]

  • 10. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ, TAXUS-IV Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):253-61. PubMed ID: 16843171
    [Abstract] [Full Text] [Related]

  • 11. Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials.
    Bainbridge D, Cheng D, Martin J, Novick R, Evidence-based Peri-operative Clinical Outcomes Research (EPiCOR) Group.
    J Thorac Cardiovasc Surg; 2007 Mar 18; 133(3):623-31. PubMed ID: 17320555
    [Abstract] [Full Text] [Related]

  • 12. eComment: Costs of percutaneous coronary intervention versus coronary artery bypass surgery.
    Almeida RM.
    Interact Cardiovasc Thorac Surg; 2009 Jun 18; 8(6):672. PubMed ID: 19443497
    [No Abstract] [Full Text] [Related]

  • 13. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA, Henry TD, Kennard ED, Kelsey SF, Michaels AD, IEPR Investigators.
    Cardiovasc Revasc Med; 2007 Jun 18; 8(3):161-5. PubMed ID: 17765644
    [Abstract] [Full Text] [Related]

  • 14. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
    Hlatky MA, Melsop KA, Boothroyd DB, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators.
    Am J Cardiol; 2006 Jun 19; 97(12A):59G-65G. PubMed ID: 16813739
    [Abstract] [Full Text] [Related]

  • 15. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z, Spertus JA, Mahoney EM, Booth J, Nugara F, Stables RH, Weintraub WS.
    Am Heart J; 2005 Jul 19; 150(1):175-81. PubMed ID: 16084166
    [Abstract] [Full Text] [Related]

  • 16. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W, European Society of Cardiology.
    Eur Heart J; 2005 Jun 19; 26(12):1169-79. PubMed ID: 15802360
    [Abstract] [Full Text] [Related]

  • 17. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial.
    Kaiser C, Kuster GM, Erne P, Amann W, Naegeli B, Osswald S, Buser P, Schläpfer H, Brett W, Zerkowski HR, Schindler C, Pfisterer M, TIME Investigators.
    Eur Heart J; 2004 Jun 19; 25(12):1036-42. PubMed ID: 15191774
    [Abstract] [Full Text] [Related]

  • 18. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
    Gray DT, Veenstra DL.
    J Thorac Cardiovasc Surg; 2003 Mar 19; 125(3):618-24. PubMed ID: 12658204
    [Abstract] [Full Text] [Related]

  • 19. [Cost-effectiveness analysis of an invasive therapeutic approach to coronary disease].
    Urban P.
    Schweiz Med Wochenschr; 1996 Sep 28; 126(39):1661-4. PubMed ID: 8927970
    [Abstract] [Full Text] [Related]

  • 20. Enhanced external counterpulsation--a therapeutic option for patients with chronic cardiovascular problems.
    Linnemeier G.
    J Cardiovasc Manag; 2002 Sep 28; 13(6):20-5. PubMed ID: 12500419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.